Skip to main content
. 2017 May 10;8(23):37761–37772. doi: 10.18632/oncotarget.17781

Table 2. Association of selected SNPs with plasma levels of MTX at 48 h from the first MTX infusion.

SNPs Median (Min-Max) (μmol/L) P
SLCO1B1 rs11045879 0.287
CC +TC 0.50 (0.09–41.63)
TT 0.39 (0.12–19.88)
SLCO1B1 rs4149056 0.441
TC+TT 0.45 (0.09–41.63)
CC 1.1. (0.15–7.53)
SLCO1B1 rs2306283 0.294
CC +TC 0.45 (0.09–41.63)
TT 0.37 (0.12–3.91)
SLCO1B1 rs10841753 0.017
TC+TT 0.47 (0.09–41.63)
CC 0.32 (0.14–5.50)
SLC19A1 rs1051266 0.384
AA +AG 0.41 (0.09–34.05)
GG 0.59 (0.14–41.63)
SLC19A1 rs3788200 0.491
AG+GG 0.45 (0.09–41.63)
AA 0.47 (0.11–34.05)
SLC19A1 rs1131596 0.219
TC+CC 0.41 (0.09–34.05)
TT 0.6 (0.14–41.63)
SLC19A1 rs2838958 0.259
AG+GG 0.41 (0.09–34.05)
AA 0.59 (0.16–41.63)
ABCB1 rs1128503 0.149
TC+CC 0.47 (0.09–19.88)
TT 0.39 (0.12–41.63)
ABCB1 rs1045642 0.340
TC+TT 0.41 (0.12–41.63)
CC 0.46 (0.09–10.88)
ABCG2 rs2231137 0.688
AG+GG 0.45 (0.09–41.63)
AA 0.46 (0.15–10.29)

SNP: single nucleotide polymorphism.